Metastatic gpNMB Expressing Triple Negative Breast Cancer
1 clinical trials · Condition
◉ Watch Metastatic gpNMB Expressing Triple Negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Individual Patient Expanded Access-Glembatumumab Vedotin (NCT03067935) | Celldex Therapeutics |
Track Metastatic gpNMB Expressing Triple Negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.